Same-day transradial outpatient stenting with a 6-hr course of glycoprotein IIb/IIIa receptor blockade: A feasibility study

被引:29
作者
Gilchrist, IC [1 ]
Nickolaus, MJ [1 ]
Momplaisir, T [1 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA
关键词
angioplasty; transluminal; percutaneous coronary; stents;
D O I
10.1002/ccd.10093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to explore the feasibility of same-day outpatient stent placement using a short course of intravenous antiplatelet therapy. Patients (n = 26) had stent placement and 6 hr of eptifibatide therapy. Demographics, procedural information, CPK data, and length of stay were recorded along with postdischarge outcomes. Twenty-one men and five women with median age of 60 years (49,69) underwent transradial stenting. Baseline characteristics included diabetes 62%, hyperlipidemia 77%, prior coronary bypass surgery 19%, and unstable angina 35%. There were no CPK elevations (> 2 x normal) or ECG changes. Discharge occurred after 6.5 hr (5.8, 7.0). Neither vascular site complications nor readmission for procedure-related problems occurred. One patient later expressed concerns about discharge education. Outpatient stent placement with 6-hr infusion of GP IIb/IIIa inhibitor appears feasible and efficient in select patients. There may be challenges to meet with regard to patient education. Further studies with larger populations are needed to evaluate and optimize this approach.
引用
收藏
页码:10 / 13
页数:4
相关论文
共 16 条
[1]  
Bachour FA, 2001, J AM COLL CARDIOL, V37, p84A
[2]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[3]   Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade - Comparison of transradial vs transfemoral arterial access [J].
Choussat, R ;
Black, A ;
Bossi, I ;
Fajadet, J ;
Marco, J .
EUROPEAN HEART JOURNAL, 2000, 21 (08) :662-667
[4]   Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison [J].
Cooper, CJ ;
El-Shiekh, RA ;
Cohen, DJ ;
Blaesing, L ;
Burket, MW ;
Basu, A ;
Moore, JA .
AMERICAN HEART JOURNAL, 1999, 138 (03) :430-436
[5]   INCIDENCE, PREDICTORS, AND MANAGEMENT OF ACUTE CORONARY-OCCLUSION AFTER CORONARY ANGIOPLASTY [J].
DEFEYTER, PJ ;
DEJAEGERE, PPT ;
SERRUYS, PW .
AMERICAN HEART JOURNAL, 1994, 127 (03) :643-651
[6]  
Gilchrist IC, 2000, CIRCULATION, V102, P640
[7]   Outpatient coronary stent implantation [J].
Kiemeneij, F ;
Laarman, GJ ;
Slagboom, T ;
vanderWieken, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) :323-327
[8]   A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The access study [J].
Kiemeneij, F ;
Laarman, GJ ;
Odekerken, D ;
Slagboom, T ;
vanderWieken, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (06) :1269-1275
[9]   DIFFERENTIAL INHIBITION OF PLATELET-AGGREGATION INDUCED BY ADENOSINE-DIPHOSPHATE OR A THROMBIN RECEPTOR-ACTIVATING PEPTIDE IN PATIENTS TREATED WITH BOLUS CHIMERIC 7E3 FAB - IMPLICATIONS FOR INHIBITION OF THE INTERNAL POOL OF GPIIB/IIIA RECEPTORS [J].
KLEIMAN, NS ;
RAIZNER, AE ;
JORDAN, R ;
WANG, AL ;
NORTON, D ;
MACE, KF ;
JOSHI, A ;
COLLER, BS ;
WEISMAN, HF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (07) :1665-1671
[10]   Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade [J].
Mascelli, MA ;
Lance, ET ;
Damaraju, L ;
Wagner, CL ;
Weisman, HF ;
Jordan, RE .
CIRCULATION, 1998, 97 (17) :1680-1688